Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-14 23:21 | 2017-03-13 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; EVP, Clinical Services | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.40 | 14,104 | $1,133,962 | 8,697 | -61.9% |
| 2016-04-06 02:21 | 2016-04-01 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; EVP & Pres, CVS MinuteClinic | Retail-Drug Stores and Proprietary Stores | SALE | $105.00 | 2,844 | $298,620 | 11,041 | -20.5% |
| 2015-04-13 23:20 | 2015-04-10 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; EVP & Pres, CVS/minuteclinic | Retail-Drug Stores and Proprietary Stores | OPT+S | $102.38 | 17,638 | $1,805,830 | 8,861 | -66.6% |
| 2015-01-06 01:00 | 2015-01-02 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; SVP & Pres, CVS/minuteclinic | Retail-Drug Stores and Proprietary Stores | SALE | $95.67 | 4,220 | $403,713 | 2,817 | -60.0% |
| 2014-09-03 23:43 | 2014-09-02 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; SVP & President, MinuteClinic | Retail-Drug Stores and Proprietary Stores | OPT+S | $79.45 | 9,020 | $716,639 | 7,037 | -56.2% |
| 2013-09-05 23:00 | 2013-09-04 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; SVP & President, MinuteClinic | Retail-Drug Stores and Proprietary Stores | OPT+S | $58.36 | 9,020 | $526,398 | 3,963 | -69.5% |
| 2012-10-05 23:09 | 2012-10-04 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; SVP & President, MinuteClinic | Retail-Drug Stores and Proprietary Stores | OPT+S | $49.00 | 9,020 | $441,980 | 3,929 | -69.7% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.